GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group AS (CHIX:PEGc) » Definitions » Enterprise Value

Pharma Equity Group AS (CHIX:PEGC) Enterprise Value : kr156.81 Mil (As of Jul. 10, 2025) ***


View and export this data going back to 2016. Start your Free Trial

What is Pharma Equity Group AS Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharma Equity Group AS's Enterprise Value is kr156.81 Mil. Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr-21.28 Mil. Therefore, Pharma Equity Group AS's EV-to-EBIT ratio for today is -7.37.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pharma Equity Group AS's Enterprise Value is kr156.81 Mil. Pharma Equity Group AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was kr-20.91 Mil. Therefore, Pharma Equity Group AS's EV-to-EBITDA ratio for today is -7.50.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pharma Equity Group AS's Enterprise Value is kr156.81 Mil. Pharma Equity Group AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil. Therefore, Pharma Equity Group AS's EV-to-Revenue ratio for today is .

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Pharma Equity Group AS's Enterprise Value is kr156.81 Mil. Pharma Equity Group AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr-22.86 Mil. Therefore, Pharma Equity Group AS's EV-to-FCF ratio for today is -6.86.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Pharma Equity Group AS Enterprise Value Historical Data

The historical data trend for Pharma Equity Group AS's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group AS Enterprise Value Chart

Pharma Equity Group AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.78 56.14 59.86 1,046.38 1,233.97

Pharma Equity Group AS Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,046.38 1,057.40 1,063.41 1,069.31 1,233.97

Competitive Comparison of Pharma Equity Group AS's Enterprise Value

For the Biotechnology subindustry, Pharma Equity Group AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Equity Group AS's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group AS's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group AS's Enterprise Value falls into.


;
;

Pharma Equity Group AS Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Pharma Equity Group AS's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Pharma Equity Group AS's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Equity Group AS  (CHIX:PEGc) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Pharma Equity Group AS's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=156.806/-21.278
=-7.37

Pharma Equity Group AS's current Enterprise Value is kr156.81 Mil.
Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-21.28 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Pharma Equity Group AS's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=156.806/-20.906
=-7.50

Pharma Equity Group AS's current Enterprise Value is kr156.81 Mil.
Pharma Equity Group AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20.91 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Pharma Equity Group AS's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=156.806/0
=

Pharma Equity Group AS's current Enterprise Value is kr156.81 Mil.
Pharma Equity Group AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Pharma Equity Group AS's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=156.806/-22.861
=-6.86

Pharma Equity Group AS's current Enterprise Value is kr156.81 Mil.
Pharma Equity Group AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-22.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Equity Group AS Enterprise Value Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group AS's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Equity Group AS Business Description

Traded in Other Exchanges
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .

Pharma Equity Group AS Headlines

No Headlines